Clinical Trial CTSUBRENB-43-M

Title

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Principal Investigator(s)

John Murray

Details

  • Protocol No. CTSUBRENB-43-M
  • Open Date: 04/26/2012
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites: Breast
  • Therapies: Molecular Targeted Agents / Immunotherapy / Biologics; Radiotherapy
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College
  • Secondary Protocol No: b-43

Description

Eligibility

Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.